Skip to main content
STRO logo

STRO · Sutro Biopharma, Inc. · Analyst Estimates

Track STRO — free
$16.35 +1.01 (+6.58%)
Market Cap
$254.36M
Shares
16.58M

Analyst Estimates

Compare analyst forecasts for Sutro Biopharma, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 20:32 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-10.32
-7.77
-6.39
-8.4725
-8.4725
-8.4725
-8.325
EPS
analysts
Publication date not stated
3
0
0
2
2
Revenue
USD
Publication date not stated
29362000
51553630
124400000
Revenue
analysts
Publication date not stated
12

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-10.4
-6.2125
-4.31
-6.385
-6.385
-6.385
-6.31
EPS
analysts
Publication date not stated
4
1
1
1
1
Revenue
USD
Publication date not stated
0
31591780
69236110
Revenue
analysts
Publication date not stated
13

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.38
-2.07
-1.45
-2.53333
-2.53333
-2.53333
-2.37
EPS
analysts
Publication date not stated
3
0
0
2
2
Revenue
USD
Publication date not stated
2500000
13619000
50000000
Revenue
analysts
Publication date not stated
12

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.75
-2.36
-1.87
-2.65
-2.65
-2.65
-2.4
EPS
analysts
Publication date not stated
3
1
1
1
1
Revenue
USD
Publication date not stated
-362000
13593460
50000000
Revenue
analysts
Publication date not stated
12
Key facts CIK 1382101 CUSIP 869367201 13F (30d) 2 filings 2 filers Visit website Investor relations